| Dr Alan R Klepper, OD | |
|
115 E Call St, Algona, IA 50511-2451 | |
| (515) 295-2196 | |
| Not Available |
| Full Name | Dr Alan R Klepper |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 35 Years |
| Location | 115 E Call St, Algona, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427084789 | NPI | - | NPPES |
| 1899 | Other | IA | STATE LICENSE # |
| 2069328 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1899 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Klepper And Trainer Partnership | 5496756637 | 2 |
News Archive
eMix, a new business venture incubated by DR Systems, today announced an additional list of medical facilities that are taking part in beta trials of eMix, the cloud-based technology for sharing imaging studies and reports. Earlier, eMix had announced a partial list of participating facilities.
Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce today that they have initiated the first-in-human clinical study of OBT357 (MEN1112), a novel enhanced antibody for the treatment of acute myeloid leukemia (AML).
Ashraf Ibrahim, Ph.D., principal investigator at LA BioMed who specializes in infectious diseases, was recently honored by the American Society for Microbiology (ASM) and the ICAAC Program Committee in the area of Therapy and Prevention of Microbial Disease.
Intentionally sedating patients to unconsciousness until death is neither widely practiced nor supported by US physicians, a national survey indicates.
› Verified 8 days ago
| Provider Name | Klepper And Trainer Partnership |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1730119710 PECOS PAC ID: 5496756637 Enrollment ID: O20070130000771 |
News Archive
eMix, a new business venture incubated by DR Systems, today announced an additional list of medical facilities that are taking part in beta trials of eMix, the cloud-based technology for sharing imaging studies and reports. Earlier, eMix had announced a partial list of participating facilities.
Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce today that they have initiated the first-in-human clinical study of OBT357 (MEN1112), a novel enhanced antibody for the treatment of acute myeloid leukemia (AML).
Ashraf Ibrahim, Ph.D., principal investigator at LA BioMed who specializes in infectious diseases, was recently honored by the American Society for Microbiology (ASM) and the ICAAC Program Committee in the area of Therapy and Prevention of Microbial Disease.
Intentionally sedating patients to unconsciousness until death is neither widely practiced nor supported by US physicians, a national survey indicates.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan R Klepper, OD 1511 W Valley View Dr, Algona, IA 50511-7269 Ph: (515) 295-5827 | Dr Alan R Klepper, OD 115 E Call St, Algona, IA 50511-2451 Ph: (515) 295-2196 |
News Archive
eMix, a new business venture incubated by DR Systems, today announced an additional list of medical facilities that are taking part in beta trials of eMix, the cloud-based technology for sharing imaging studies and reports. Earlier, eMix had announced a partial list of participating facilities.
Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce today that they have initiated the first-in-human clinical study of OBT357 (MEN1112), a novel enhanced antibody for the treatment of acute myeloid leukemia (AML).
Ashraf Ibrahim, Ph.D., principal investigator at LA BioMed who specializes in infectious diseases, was recently honored by the American Society for Microbiology (ASM) and the ICAAC Program Committee in the area of Therapy and Prevention of Microbial Disease.
Intentionally sedating patients to unconsciousness until death is neither widely practiced nor supported by US physicians, a national survey indicates.
› Verified 8 days ago
John C. Kortenber Optometry Pc Optometrist Medicare: Medicare Enrolled Practice Location: 112 N Thorington St, Algona, IA 50511 Phone: 515-395-3937 Fax: 515-395-3938 | |
Dr. Donald J Kingfield, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 220 N Dodge St, Algona, IA 50511 Phone: 515-295-3743 Fax: 515-295-2653 | |
James R Schuchert, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 115 E Call St, Algona, IA 50511 Phone: 515-295-2196 Fax: 515-295-7964 | |
Dr. Tony N Trainer, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 115 E Call St, Algona, IA 50511 Phone: 515-295-2196 Fax: 515-295-7964 | |
Schuchert And Klepper Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 115 E Call St, Algona, IA 50511 Phone: 515-295-2196 Fax: 515-295-7964 | |
Klepper And Trainer Partnership Optometrist Medicare: Medicare Enrolled Practice Location: 115 E Call St, Algona, IA 50511 Phone: 515-295-2196 Fax: 515-295-7964 |